Nike shareholders overwhelmingly rejected a request on September 8 to disclose the company's spending on political activism and charitable donations. The proposal, which sought clarity on LGBTQ+ health benefits, failed to secure even 1% of the vote.

Advertisement

The less-than-1% mandate for Proposal 5

During Nike's annual meeting on September 8, shareholders decisively voted against "Proposal 5," a resolution that asked the company to analyze the risks and costs associated with its charitable support. According to a September 10 SEC filing,the proposal received less than 1% of the votes cast for or against it, signaling a lack of appetite among the majority of investors for the requested disclosures.

Nike responded to the proposal by stating that its current approach to charitable giving and existing guidelines already serve the best interests of its shareholders . The company further argued that producing an additional report on these activities would consume valuable time and resources without providing any meaningful added value to the investor base.

The Human Rights Campaign's 100-point score and minor dependents

The push for transparency was led by Inspire Investing, a faith-based firm representing investors such as William C. Cunningham. Tim Schwarzenberger, a director at Inspire Investing, pointed to Nike's perfect score of 100 on the Human Rights Campaign's (HRC) Corporate Equality Index as a catalyst for the proposal. Inspire Investing argued that this score suggests Nike may be adhering to an increasingly left-wing set of corporate requirements that could pose reputational or financial risks.

A central point of contention remains whether Nike's employee health plans cover gender-transition procedures for minor dependents, including puberty blockers, cross-sex hormone therapy, and surgery. As reported in the source, Nike has not publicly confirmed if these specific benefits are provided to minors, and while the HRC's 2026 criteria require such benefits for full credit, Nike's public profile does not disclose age limits or dependent-specific terms.

A $200 billion market cap slide and the S&P 100 exit

This internal debate over corporate activism arrives as Nike faces significant financial headwinds. the company is scheduled to be removed from the S&P 100 index before trading begins on September 21, ending a tenure of nearly 18 years in the blue-chip index. s&P Dow Jones Indices indicated that this rebalance is necessary to ensure the index remains representative of current market-cap ranges.

The removal from the index mirrors a broader decline in Nike's valuation. Since its market peak in November 2021, the company's market capitalization has plummeted by more than $200 billion. This financial erosion suggests that while a small minority of investors are focused on political activism, the company is grappling with a much larger crisis of valuation and market position.

The 13% revenue drop in Greater China

Beyond its valuation struggles in the U.S., Nike is losing ground in critical international markets. According to the report, Nike's revenue in Greater China fell by 13% on a currency-neutral basis in fiscal 2026. This decline highlights the company's vulnerability in a region that has historically been a primary engine of growth.

The revenue slump in China is compounded by the rise of newer competitors and ongoing product challenges . For investors like those represented by Inspire Investing, the combination of financial instability and perceived political overreach creates a volatile environment, though the overwhelming vote against Proposal 5 suggests that the broader shareholder base is not yet linking the two issues.